The Bone Marrow Transplant Program at Miami Children’s Hospital is the region’s first and most experienced care provider for children requiring bone marrow transplantation. Established in 1991, the program was originally accredited in 2003 by the Foundation for the Accreditation of Cellular Therapies (FACT) for all aspects of bone marrow transplantation and has consistently maintained the rigorous qualifications necessary to ensure its continued standing over the years. The program is also an accredited center for transplants under the auspices of the Children’s Oncology Group and is a member of the Pediatric Bone Marrow Transplant Consortium and the International Blood and Marrow Transplant Registry. Membership in these organizations brings access to the very latest national and international research data.
Bone marrow transplantation is used to treat the following:
• Acute lymphocytic leukemia (ALL)
• Acute non-lymphocytic leukemia (AML)
• Chronic myelogenous leukemia (CML)
• Sickle cell disease
• Hemophagocytic lymphohistiocytosis (HLH)
• Severe beta thalassemia
• Anemias (aplastic, Fanconi)
• Metabolic storage diseases
The Bone Marrow Transplant Programs is part of the National Bone Marrow Donor Program, enabling the hospital to locate unrelated donors for patients in need.
The Bone Marrow Transplant Unit is a private enclave within the hospital’s pediatric hematology-oncology wing, and is staffed by highly trained and experienced nursing and care coordination staff, as well as a social worker and pharmacist.
The Pediatric Bone Marrow Transplant
program at Miami Children's Hospital is part of the National Marrow Donor Program, which provides
access to a large, diverse donor pool. Our NMDP association has enabled us not only to locate unrelated donors for our patients, but also to perform these transplants at our facility, eliminating the need for relocation for many families. The program remains part of the Children's Oncology Group, International Bone Marrow Transplant registry, and The Pediatric Bone Marrow Transplant Consortium. Membership in these organizations enables the BMT program to participate in a number of clinical research protocols, and to have access to very latest research data. Download the Bone Marrow Transplant Mailer (PDF)